...and measurable results. "We cannot let this momentum wane. Now is the time to redouble our efforts, and save many more lives." Antiretroviral therapy has also made a significant impact in preventing new infections in children as more...

In this article: HIV, AIDS, Population growth, Antiretroviral therapy, Margaret Chan, World Health Organization, Botswana, and Pakistan

...is currently running a multicenter, multidose, open label phase 2 clinical trial of SCV-07 as a monotherapy and in combination with ribavirin to treat patients infected with hepatitis C virus, who have relapsed after the last treatment.

In this article: Mucositis, Cancer, Stat3, Medical advice, Ribavirin, Cisplatin, Peptide, Hepatitis, and Head and neck cancer

...lungs, mechanically supplying oxygen to the patient's blood and removing carbon dioxide. The other is an intravenous flu medicine called peramivir (per-AM-uh-veer), which last month received emergency approval for use from the federal...

In this article: FLU, Peramivir, and Oxygen

Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole , or HIV drugs like ritonavir. UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment.

In this article: Avanafil, Levitra, Cialis, Viagra, Cancer, Ritonavir, and Ketoconazole

...provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on Hemispherx Biopharma (AMEX:HEB) after releasing the latest short sale data to November 20, 2009. From...

In this article: Hemispherx Biopharma, Short squeeze, U.S., Newport Beach, and California

...said. Investors could flee if retigabine is not approved by regulators or if it is approved but fails to offset a waning royalties from ribavirin , Valeant's biggest product, it said. The story noted that Valeant trades at 10 times trailing...

In this article: Cash flow, Ribavirin, Epilepsy, Valeant Pharmaceuticals International, Biovail Corp, Cephalon Inc, New York Stock Exchange, and GlaxoSmithKline Pharmaceuticals

...all 5.75 million shares are sold, BioCryst's share count will rise almost 15 percent. BioCryst's most advanced drug candidate is peramivir , a flu drug intended to be given by IV to patients who are too sick to take an oral dose. Peramivir...

In this article: Peramivir, Birmingham, and Alabama

...that took her in. An 8-year-old German girl does her homework in a children's home called the Ark. A South African boy of 5 is saved by AIDS drugs. PORT-AU-PRINCE , Haiti -- Saintia Pierre was born in a country forged by a slave rebellion.

In this article: Unicef, United Nations, Moscow, Mexico City, and Beijing

...calls for study participants to be randomized to receive either the TCAD therapy comprised of amantadine and ribavirin with oseltamivir or oseltamivir monotherapy for 10 days. The follow-up period will be six months following treatment and an...

In this article: Influenza, Oseltamivir, Ribavirin, Amantadine, Neuraminidase inhibitor, California, HIV, and University of Amsterdam

...Phase 2b study conducted by Roche of ITMN-191 (RG7227) combined with standard of care (SOC) PEGASYS® (peginterferon alfa-2a) and COPEGUS ® ( ribavirin ) in HCV treatment-naive patients has been modified. The Phase 2b study has four dosage...

In this article: Pegasys, Ribavirin, Protease inhibitor, SEC, Medical advice, Annual report, Ritonavir, and Securities Exchange Act of 1934

... Schuchat said. The CDC said doctors need to treat severe cases quickly with antiviral drugs such as Tamiflu , made by Roche AG , Relenza , made by GlaxoSmithKline or for especially grave hospitalized cases, peramivir , made by BioCryst.

In this article: United States, Relenza, Peramivir, Tamiflu, GlaxoSmithKline, and U.S. Centers for Disease Control and Prevention

...leadership tenure Pfizer discovered and/or developed a number of important new medicines including Tarceva , Chantix , Zoloft (PTSD), Selzentry and Lyrica along with a number of other medicines currently in late stage development for cancer ,...

In this article: Pfizer Inc, University of New Hampshire, Boston College, Chemistry, and New England School of Law

...of seven potential treatments, five of which are in phase II development. Dr Limet highlighted the potential of Pfizer 's anti-viral drug Selzentry , which stimulates the patient's immune system, as a growth driver. The merged HIV...

In this article: HIV, GlaxoSmithKline, Pfizer, Revenue, Selzentry, and London

...of Liver Diseases' annual meeting in Boston. Vierling said 85 to 87 percent of patients who took narlaprevir, ritonavir , Pegintron and ribavirin after lead-in treatment also achieved early virologic response (EVR), defined as undetectable...

In this article: Hepatitis, Ribavirin, Schering-Plough, Telaprevir, Boceprevir, American Association, Ritonavir, and HIV

CAMBRIDGE , Mass. -- Vertex Pharmaceuticals Inc. said Wednesday its hepatitis C treatment telaprevir created an immune system response to the virus in patients who had not been helped by other drugs. The results came from a midstage trial...

In this article: Telaprevir, Vertex, Hepatitis, The Miami Herald, Cambridge, and Massachusetts

... EU. Corifollitropin Alfa, Mometasone Formoterol or [Dalera] and Nomac/E2 and we also filed a new version of Implanon. Meanwhile for Vicriviroc we plan to have a key FDA meeting this quarter before we initiate the rolling NDA process. In Japan...

In this article: Schering-Plough, Fred Hassan, FDA, Merck, Boceprevir, Nasonex, Sugammadex, and Temodar

...percent of treatment-naive patients have virus that uses the CCR5 co-receptor.(3) The study evaluates vicriviroc 30 mg once-daily in combination with ritonavir -boosted atazanavir,(4) compared to a control group receiving Truvada...

In this article: Vicriviroc, Schering-Plough, HIV, Ritonavir, CCR5, Truvada, Protease inhibitor, Atazanavir, Nucleoside, and Bristol-Myers Squibb Company

...Phase III clinical studies in treatment-experienced HIV patients. Key Safety Findings with Vicriviroc A pooled data analysis was conducted for two vicriviroc Phase II studies involving 205 treatment-experienced HIV -infected patients who...

In this article: Vicriviroc, HIV, Schering-Plough, Atazanavir, Truvada, Ritonavir, Reverse transcriptase inhibitor, CCR5, Nucleoside, and Myocardial infarction